| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 22 |
| 1 | TACROLIMUS | 22 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 3 | TACROLIMUS OINTMENT 0.1% | 22 |
| 4 | CYCLOSPORINE | 21 |
| 5 | PEMBROLIZUMAB | 19 |
| 6 | METHOTREXATE SODIUM | 14 |
| 7 | SECUKINUMAB | 14 |
| 8 | METHOTREXATE | 13 |
| 9 | METHYLPREDNISOLONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 1 | MEFENAMIC ACID | 7 | 0.0032 |
| 2 | CALCIFEDIOL | 5 | 0.0020 |
| 3 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 4 | TREOSULFAN | 4 | 0.0014 |
| 5 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| 6 | DECITABINE | 4 | 0.0009 |
| 7 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 9 | BUSULFAN | 10 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Interleukin-17A Antagonist [EPC] | 14 | 0.0004 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 28 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 21 | 0.0002 |
| 6 | Aminosalicylate [EPC] | 11 | 0.0001 |
| 7 | Antirheumatic Agent [EPC] | 11 | 0.0001 |
| 8 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 11 | 0.0001 |